LogoLogoLogoLogoLogo
  • Home
  • About
  • Lock-Release Technology
  • Bio-conjugation Services
  • News
  • Careers
  • Contact
  • Home
  • About
  • Lock-Release Technology
  • Bio-conjugation Services
  • News
  • Careers
  • Contact
14 Nov

ADC Bio Secures Additional Equity Round Investment

in Uncategorized
0 Comments
by ADC Admin

Extra funding for strategic move into downstream formulation and fill-finish capabilities and full exploitation of Lock-Release as new ADC manufacturing paradigm...

26 Apr

Poster dedicated to Lock Release Technology presented at 14th Annual PEGS Boston Conference

in Uncategorized
0 Comments
by ADC Admin

Conjugation Process Improvements – Application of Lock Release Technology – Poster presented at the Protein Engineering Summit (Boston)...

25 Apr

ADC Bio secures £1.14m investment from Downing LLP

in Uncategorized
0 Comments
by ADC Admin

ADC Biotechnology has successfully secured a £1.14m investment from Downing LLP to finance innovative bioconjugation and their US expansion plans...

29 Mar

ADC Bio presents Process Technology at Berlin Conference

in Uncategorized
0 Comments
by ADC Admin

ADCBIO presented at World ADC Conference on their conjugation process technologies...

04 Feb

Developing A Downstream Bio-Conjugation Process.

in Uncategorized
0 Comments
by ADC Admin

ADC BIO announces the development of a revolutionary, ‘downstream bio-conjugation’ method that will present a new paradigm in Antibody Drug Conjugate (ADC) development and manufacturing....

05 Dec

WHP BUILD CONTRACT AGREED.

in Uncategorized
0 Comments
by ADC Admin

ADC BIO has signed a partnership agreement with multi-disciplined engineering specialists, WHP. ...

14 Nov

Poor aggregation will see ADC targets fail or face long delays.

in Uncategorized
0 Comments
by ADC Admin

Experts at ADC Bio warn of impending problems in the ADC pipeline with millions wasted in development costs....

25 Sep

ADC BIO Secures $11 Million Facilities Investment.

in Uncategorized
0 Comments
by ADC Admin

ADC BIO has secured investment for the construction of an $11 million bioconjugation facility at its new site in Deeside, North Wales, UK. ...

OUR INVESTORS

 

© Copyright 2018 ADC Biotechnology Ltd.
Privacy Notice  |  Privacy Notice for Job Applicants  |  Cookie Policy

Cookie Consent

Like most websites, ADC BIO uses cookies to help give you the best possible experience. They also help us to monitor how many people are using the site and how it performs. Find out more.